feature photo

Resources

Funding Acknowledgements and Disclaimer

Each publication, presentation, press release or other documents will include a statement acknowledging the IMPAACT Network and must include an acknowledgement of National Institutes of Health (NIH) award support for the work and list the applicable grant award numbers.

Press Releases: prior to issuing a press release, the NIAID Program Officer must be notified in advance to allow for NIH review and approval coordination.

Please note that several of the suggested acknowledgements below require referencing additional grant award numbers and/or contract numbers, contact co-authors to ensure all applicable grant awards and/or contract numbers are acknowledged.

There should be a reference to the specific protocol number in the description of study methods.

  • Grant award numbers for the IMPAACT LOC, SDMC (if applicable), LC (if applicable), NIAID-funded CTUs, and NICHD-funded sites to which the masthead authors are affiliated must all appear in the acknowledgments.
  • Disclaimer on behalf of NIH shall read as follows: “Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.”

For studies originating under the HPTN (including, but not limited to HPTN 027, 035, 046, 057, 059), please use the following acknowledgment (note we recognize this may be combined with other funding sources): “This study was supported by the HIV Prevention Trials Network (HPTN) and was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1AI046749, with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health and Office of AIDS Research.”

 

 

 

 

 

 

 

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.